is saxenda a glp 1 drug (Liraglutide) Regulator keeps close eye on

Assessing the safety of sitagliptin in older participants in the trial evaluating cardiovascular outcomes with sitagliptin (TECOS)

This approach requires medical supervision but can be extremely effective

doi: 10.2337/diacare.27.11.2628 [DOI] [PubMed] [Google Scholar] 213

The study concluded that in patients with obesity-related heart failure and T2DM with preserved ejection fraction, semaglutide treatment resulted in significantly greater reductions in heart failure-related symptoms and physical limitations, as well as more pronounced weight loss at one year compared to placebo

Role of lateral septum glucagon-like peptide 1 receptors in food intake